4G Clinical Launches Direct-to-Patient Platform


Applied Clinical Trials

4G Clinical has announced the launch of a Direct-to-Patient (DtP) clinical trial platform, offering sponsors the flexibility to ship drug from the sites to the patient's home. In the midst of the COVID-19 pandemic, clinical trial models are shifting towards DtP to address patient safety & access to trial sites, site capacity challenges, and supply chain disruption.  

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.